Financial News
Orthocell welcomes globally recognised nerve surgeons to advisory board
March 30, 2023 at 15:30 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
Orthocell Ltd (ASX:OCC) MD Paul Anderson tells Proactive the company has appointed two internationally recognised orthopaedic surgeons specialising in nerve transfer and peripheral nerve repair, Professor Christopher Dy and Professor David Brogan, to the company’s Medical Scientific Advisory Board (MSAB). Professors Dy and Brogan are based at Washington University and Barnes-Jewish Orthopedic Center, one of the US’s leading academic research institutions and hospitals, and have been appointed to assist with clinical development and US market access for Orthocell’s nerve repair medical device.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
What abrdn (ABDN) Said on Its Q3 Earnings Call ↗
Today 6:02 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
